Sutton Wealth Advisors Inc. Ironwood Pharmaceuticals Inc Transaction History

Sutton Wealth Advisors Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$10.37 - $12.56 $93 - $113	-9 Closed	0 $0
Q4 2022 Nov 07, 2023	SELL	$9.9 - $12.43 $16,948 - $21,280	-1,712 Reduced 99.48%	9 $112,000
Q3 2022 Nov 07, 2023	BUY	$10.14 - $12.38 $17,106 - $20,885	1,687 Added 4961.76%	1,721 $17.8 Million
Q2 2022 Nov 07, 2023	BUY	$11.05 - $12.72 $375 - $432	34 New	34 $392,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.